Intraductal Radiofrequency Thermoablation and Radiotherapy Combined Treatment for Extrahepatic Cholangiocarcinoma

NARecruitingINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2030

Conditions
Biliary Tract CarcinomaRadiotherapyRadio-frequency Ablation
Interventions
PROCEDURE

ID-RFA and Radiotherapy

The histologic or cytologic examination will be performed at the time of the first biliary drainage, and the extent of the cholangiocarcinoma lesion will be assessed during the procedure. After the diagnosis of extrahepatic cholangiocarcinoma, ID-RFA will be performed, and a biliary stent will be inserted for biliary drainage. Radiotherapy will be performed within 1 month of ID-RFA.

Trial Locations (1)

10408

RECRUITING

National Cancer Center, Korea, Goyang-si

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

National Cancer Center, Korea

OTHER_GOV